ActivBiotics Files Registration Statement For Proposed Initial Public Offering

LEXINGTON, Mass., Aug. 14 /PRNewswire/ -- ActivBiotics, Inc. today announced that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock. All shares of common stock to be sold in the offering will be sold by ActivBiotics, Inc.

HSBC Securities (USA) Inc. will be acting as the book-running manager and Needham & Company, LLC, BMO Capital Markets Corp. and Susquehanna Financial Group, LLLP will be acting as co-managers in this offering.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but it has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time that the registration statement becomes effective. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. When available, a preliminary prospectus may be obtained from HSBC Securities (USA) Inc. by contacting Mayda Poc of the Equity Capital Markets department at 452 5th Avenue, New York, New York 10018, or by telephone at 212-525-5000.

ActivBiotics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of inflammatory diseases and bacterial infections. For more information on ActivBiotics, Inc., please visit our web site at: http://www.activbiotics.com.

Safe Harbor Statement

This press release may contain or incorporate by reference certain statements that are not historical facts, including statements preceded by, followed by or that include the words "may," "believes," "will", "expects," "anticipates," or the negation thereof, or similar expressions, which constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). All statements that address events, transactions or developments that are expected or anticipated to occur in the future are forward-looking statements within the meaning of the Reform Act. Such forward-looking statements involve risks, uncertainties and other factors that may cause the actual performance or achievements of ActivBiotics, Inc. to be materially different from any future results, performance or achievements expressed or implied by such forward- looking statements. For those statements, ActivBiotics, Inc. claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. ActivBiotics, Inc. will not undertake and specifically declines any obligation to publicly release the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Source: ActivBiotics, Inc.

>>> Discuss This Story

Back to news